Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)

NCT01657331 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Anaplastic Large Cell Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: Bendamustine
DRUG: Neulasta

Sponsor

Columbia University